Signals flagged in the original
Provisional estimate — refines shortly Full breakdown ↓
Critics of the Inflation Reduction Act assert that it is leading to higher costs and decreased access to medications for patients. The concerns focus on the effects of price negotiations and changes to Medicare Part D.
Our neutral summary
Critics of the Inflation Reduction Act assert that it is leading to higher costs and decreased access to medications for patients. The concerns focus on the effects of price negotiations and changes to Medicare Part D.
The reporting belongs to The Hill; we don't reproduce it.
No note attached
on this article.
The Inflation Reduction Act’s broken promise is still costing patients
Critics claim Inflation Reduction Act impacts medication costs and access